IRIS
RUSSO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 313
EU - Europa 218
AS - Asia 217
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 309
CN - Cina 208
IE - Irlanda 127
FI - Finlandia 34
DE - Germania 28
IT - Italia 17
CA - Canada 4
SE - Svezia 4
SG - Singapore 4
AT - Austria 3
IN - India 3
ES - Italia 2
GR - Grecia 2
AU - Australia 1
CL - Cile 1
EG - Egitto 1
GB - Regno Unito 1
IR - Iran 1
MU - Mauritius 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
Totale 753
Salva come PNG Salva come JPEG
Città #
Dublin 127
Chandler 100
Nanjing 56
Beijing 41
Helsinki 23
Ashburn 21
Nanchang 21
Princeton 17
Jacksonville 16
Lawrence 16
Wilmington 15
Changsha 14
Medford 14
Shenyang 14
Hebei 13
Pavia 12
Shanghai 12
Jiaxing 10
Tianjin 10
Piscataway 6
Hangzhou 5
Norwalk 4
Singapore 4
Tamm 4
Toronto 3
Woodbridge 3
Athens 2
Falkenstein 2
Fuzhou 2
New York 2
Pune 2
Redwood City 2
Seattle 2
Taizhou 2
Vinovo 2
Zhengzhou 2
Ann Arbor 1
Boardman 1
Cairo 1
Cardano 1
Cervera del Rio Alhama 1
Dearborn 1
Fairfield 1
Freetown 1
Haikou 1
Jinan 1
London 1
Los Angeles 1
Markham 1
Mumbai 1
Nagold 1
Ningbo 1
Orange 1
Riyadh 1
Sacramento 1
San Francisco 1
Shiraz 1
Sydney 1
Vienna 1
Totale 624
Salva come PNG Salva come JPEG
Nome #
Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy) 65
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 63
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 56
A patient with AL amyloidosis with negative free light chain results 54
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 50
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis 49
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis 48
Prognostication of survival and progression to dialysis in AA amyloidosis 47
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome 45
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 44
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome 43
Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis 42
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 42
The lung in amyloidosis 32
null 30
Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis 30
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 30
null 29
Totale 799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020200 57 94 0 0 0 0 3 1 2 25 14 4
2020/202130 6 0 0 0 0 2 0 7 12 3 0 0
2021/202275 0 0 3 0 2 0 0 7 6 2 8 47
2022/2023301 34 33 7 15 22 25 0 13 146 0 5 1
2023/2024110 19 21 5 16 9 16 2 7 0 5 10 0
Totale 799